首页 > 最新文献

Clinical and Experimental Emergency Medicine最新文献

英文 中文
Patient-reported outcome measures in emergency and acute care: looking beyond the emergency room. 急诊和急性病护理中的患者报告结果衡量标准--超越急诊室。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2024-03-28 DOI: 10.15441/ceem.23.172
Jason B Liu, David W Bates
{"title":"Patient-reported outcome measures in emergency and acute care: looking beyond the emergency room.","authors":"Jason B Liu, David W Bates","doi":"10.15441/ceem.23.172","DOIUrl":"10.15441/ceem.23.172","url":null,"abstract":"","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"1-5"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139575284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of fall-from-height patients: a retrospective comparison of jumpers and fallers using a multi-institutional registry. 高空坠落患者的特征:采用多机构注册对跳楼者和坠落者进行回顾性比较。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2023-11-29 DOI: 10.15441/ceem.23.074
Jinhae Jun, Ji Hwan Lee, Juhee Han, Sun Hyu Kim, Sunpyo Kim, Gyu Chong Cho, Eun Jung Park, Duk Hee Lee, Ju Young Hong, Min Joung Kim

Objective: Fall from height (FFH) is a major public health problem that can result in severe injury, disability, and death. This study investigated how the characteristics of jumpers and fallers differ.

Methods: This was a retrospective study of FFH patients enrolled in an Emergency Department-based Injury In-depth Surveillance (EDIIS) registry between 2011 and 2018. Depending on whether the injury was intentional, FFH patients who had fallen from a height of at least 1 m were divided into two groups: jumpers and fallers. Patient characteristics, organ damage, and death were compared between the two groups, and factors that significantly affected death were identified using multivariable logistic analysis.

Results: Among 39,419 patients, 1,982 (5.0%) were jumpers. Of the jumpers, 977 (49.3%) were male, while 30,643 (81.9%) of fallers were male. The jumper group had the highest number of individuals in their 20s, with the number decreasing as age increased. In contrast, the number of individuals in the faller group rose until reaching their 50s, after which it declined. More thoracoabdominal, spinal, and brain injuries were found in jumpers. The in-hospital mortality of jumpers and fallers was 832 (42.0%) and 1,268 (3.4%), respectively. Intentionality was a predictor of in-hospital mortality, along with sex, age, and fall height, with an odds ratio of 7.895 (95% confidence interval, 6.746-9.240).

Conclusion: Jumpers and fallers have different epidemiological characteristics, and jumpers experienced a higher degree of injury and mortality than fallers. Differentiated prevention and treatment strategies are needed for jumpers and fallers to reduce mortality in FFH patients.

目的:高空坠落(FFH)是一个重大的公共卫生问题,可导致严重的伤害、残疾和死亡。这项研究调查了跳高者和跳高者的特点有何不同。方法:这是一项回顾性研究,研究对象是2011年至2018年间在急诊科损伤深度监测(EDIIS)登记处登记的FFH患者。根据是否故意伤害,将从1米以上高度坠落的FFH患者分为两组:跳高组和坠落组。比较两组患者特征、器官损伤和死亡情况,并使用多变量logistic分析确定显著影响死亡的因素。结果:39419例患者中,跳楼者1982例(5.0%)。跳楼者中男性977人(49.3%),跳楼者中男性30643人(81.9%)。跳楼组20多岁的人数最多,随着年龄的增长人数减少,但跳楼组的人数一直增加到50多岁,然后下降。跳楼者的胸腹、脊柱和脑部损伤较多。跳楼者和跳楼者住院死亡率分别为832(42.0%)和1268(3.4%)。意向性与性别、年龄和坠落高度一起是院内死亡率的预测因子,比值比为7.895(95%可信区间为6.746-9.240)。结论:跳楼者和落楼者具有不同的流行病学特征,跳楼者损伤程度和死亡率高于落楼者。为了降低FFH患者的死亡率,需要对跳楼者和跳楼者采取不同的预防和治疗策略。
{"title":"Characteristics of fall-from-height patients: a retrospective comparison of jumpers and fallers using a multi-institutional registry.","authors":"Jinhae Jun, Ji Hwan Lee, Juhee Han, Sun Hyu Kim, Sunpyo Kim, Gyu Chong Cho, Eun Jung Park, Duk Hee Lee, Ju Young Hong, Min Joung Kim","doi":"10.15441/ceem.23.074","DOIUrl":"10.15441/ceem.23.074","url":null,"abstract":"<p><strong>Objective: </strong>Fall from height (FFH) is a major public health problem that can result in severe injury, disability, and death. This study investigated how the characteristics of jumpers and fallers differ.</p><p><strong>Methods: </strong>This was a retrospective study of FFH patients enrolled in an Emergency Department-based Injury In-depth Surveillance (EDIIS) registry between 2011 and 2018. Depending on whether the injury was intentional, FFH patients who had fallen from a height of at least 1 m were divided into two groups: jumpers and fallers. Patient characteristics, organ damage, and death were compared between the two groups, and factors that significantly affected death were identified using multivariable logistic analysis.</p><p><strong>Results: </strong>Among 39,419 patients, 1,982 (5.0%) were jumpers. Of the jumpers, 977 (49.3%) were male, while 30,643 (81.9%) of fallers were male. The jumper group had the highest number of individuals in their 20s, with the number decreasing as age increased. In contrast, the number of individuals in the faller group rose until reaching their 50s, after which it declined. More thoracoabdominal, spinal, and brain injuries were found in jumpers. The in-hospital mortality of jumpers and fallers was 832 (42.0%) and 1,268 (3.4%), respectively. Intentionality was a predictor of in-hospital mortality, along with sex, age, and fall height, with an odds ratio of 7.895 (95% confidence interval, 6.746-9.240).</p><p><strong>Conclusion: </strong>Jumpers and fallers have different epidemiological characteristics, and jumpers experienced a higher degree of injury and mortality than fallers. Differentiated prevention and treatment strategies are needed for jumpers and fallers to reduce mortality in FFH patients.</p>","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"79-87"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138451066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calcific tendinitis of the longus colli muscle. 领长肌钙化性腱鞘炎
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2024-03-21 DOI: 10.15441/ceem.23.079
Daniel Vaccaro Sumi, Rafael Maffei Loureiro
{"title":"Calcific tendinitis of the longus colli muscle.","authors":"Daniel Vaccaro Sumi, Rafael Maffei Loureiro","doi":"10.15441/ceem.23.079","DOIUrl":"10.15441/ceem.23.079","url":null,"abstract":"","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"115-116"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10068806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study of intranasal desmopressin and intranasal ketamine for pain management in renal colic patients: a randomized double-blind clinical trial. 肾绞痛患者鼻内注射去氨加压素和鼻内注射氯胺酮止痛的比较研究:随机双盲临床试验。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2023-07-13 DOI: 10.15441/ceem.23.059
Farhad Heydari, Reza Azizkhani, Saeed Majidinejad, Majid Zamani, Aref Norouzian

Objective: Urolithiasis is one of the most common urological diseases worldwide, usually presenting as renal colic that leads to severe pain that requires analgesic treatment. This study aimed to compare the efficacy of ketamine and desmopressin in the pain management of renal colic patients.

Methods: This double-blind, randomized clinical trial was conducted on renal colic patients referred to the emergency department from June 2021 to July 2022. Patients were randomly assigned to three groups. In the desmopressin group, patients were treated with intranasal desmopressin and intravenous ketorolac. The ketamine group was treated with intranasal ketamine and ketorolac. The control group received ketorolac and an intranasal placebo. Vital signs were evaluated at baseline and 60 minutes; and pain scores were assessed at baseline, 10, 30, and 60 minutes after treatment.

Results: Enrollment included 135 patients, the mean (standard deviation) age was 44.1±11.4 years, and 82 (60.7%) were men. The mean visual analog scale scores were significantly lower at 10, 30, and 60 minutes in the ketamine group (5.6±1.2, 3.0±1.1, and 0.9±0.9, respectively) compared to the control (8.2±1.1, 5.1±2.0, and 2.3±2.6, respectively) and desmopressin (6.7±1.8, 4.2±2.2, and 1.3±1.4, respectively) groups (P<0.05). Although patients in the desmopressin group had lower mean pain scores than the control group at 10, 30, and 60 minutes, this difference was only significant at 10 minutes after the intervention (P<0.05). No significant differences in vital signs were found at 60 minutes after treatment.

Conclusion: Ketamine showed more favorable analgesic effects in renal colic patients than desmopressin, although desmopressin showed efficacy in the first minutes posttreatment.

目的:尿石症是全球最常见的泌尿系统疾病之一,通常表现为肾绞痛,导致剧烈疼痛,需要镇痛治疗。本研究旨在比较氯胺酮和去氨加压素治疗肾绞痛的疗效:这项双盲、随机临床试验针对 2021 年 6 月至 2022 年 7 月期间转诊至急诊科的肾绞痛患者。患者被随机分配到三组。去氨加压素组患者接受鼻内去氨加压素和静脉注射酮咯酸治疗。氯胺酮组采用鼻内氯胺酮和酮咯酸治疗。对照组接受酮咯酸和鼻内安慰剂治疗。在基线和治疗后 60 分钟评估生命体征;在基线、治疗后 10 分钟、30 分钟和 60 分钟评估疼痛评分:135名患者的平均年龄(标准差)为44.1±11.4岁,82名男性(60.7%)。与对照组(分别为 8.2±1.1、5.1±2.0 和 2.3±2.6)和去氨加压素组(分别为 6.7±1.8、4.2±2.2 和 1.3±1.4)相比,氯胺酮组在 10 分钟、30 分钟和 60 分钟时的平均视觉模拟量表评分(分别为 5.6±1.2、3.0±1.1 和 0.9±0.9)明显较低(PConclusion:氯胺酮对肾绞痛患者的镇痛效果优于去氨加压素,尽管去氨加压素在治疗后的最初几分钟表现出疗效。
{"title":"A comparative study of intranasal desmopressin and intranasal ketamine for pain management in renal colic patients: a randomized double-blind clinical trial.","authors":"Farhad Heydari, Reza Azizkhani, Saeed Majidinejad, Majid Zamani, Aref Norouzian","doi":"10.15441/ceem.23.059","DOIUrl":"10.15441/ceem.23.059","url":null,"abstract":"<p><strong>Objective: </strong>Urolithiasis is one of the most common urological diseases worldwide, usually presenting as renal colic that leads to severe pain that requires analgesic treatment. This study aimed to compare the efficacy of ketamine and desmopressin in the pain management of renal colic patients.</p><p><strong>Methods: </strong>This double-blind, randomized clinical trial was conducted on renal colic patients referred to the emergency department from June 2021 to July 2022. Patients were randomly assigned to three groups. In the desmopressin group, patients were treated with intranasal desmopressin and intravenous ketorolac. The ketamine group was treated with intranasal ketamine and ketorolac. The control group received ketorolac and an intranasal placebo. Vital signs were evaluated at baseline and 60 minutes; and pain scores were assessed at baseline, 10, 30, and 60 minutes after treatment.</p><p><strong>Results: </strong>Enrollment included 135 patients, the mean (standard deviation) age was 44.1±11.4 years, and 82 (60.7%) were men. The mean visual analog scale scores were significantly lower at 10, 30, and 60 minutes in the ketamine group (5.6±1.2, 3.0±1.1, and 0.9±0.9, respectively) compared to the control (8.2±1.1, 5.1±2.0, and 2.3±2.6, respectively) and desmopressin (6.7±1.8, 4.2±2.2, and 1.3±1.4, respectively) groups (P<0.05). Although patients in the desmopressin group had lower mean pain scores than the control group at 10, 30, and 60 minutes, this difference was only significant at 10 minutes after the intervention (P<0.05). No significant differences in vital signs were found at 60 minutes after treatment.</p><p><strong>Conclusion: </strong>Ketamine showed more favorable analgesic effects in renal colic patients than desmopressin, although desmopressin showed efficacy in the first minutes posttreatment.</p>","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"51-58"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009705/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10132270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point-of-care ultrasound for airway management in the emergency and critical care setting. 用于急诊和重症监护环境中气道管理的护理点超声波。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2023-11-25 DOI: 10.15441/ceem.23.094
Michael Gottlieb, James R O'Brien, Nicholas Ferrigno, Tina Sundaram

Airway management is a common procedure within emergency and critical care medicine. Traditional techniques for predicting and managing a difficult airway each have important limitations. As the field has evolved, point-of-care ultrasound has been increasingly utilized for this application. Several measures can be used to sonographically predict a difficult airway, including skin to epiglottis, hyomental distance, and tongue thickness. Ultrasound can also be used to confirm endotracheal tube intubation and assess endotracheal tube depth. Ultrasound is superior to the landmark-based approach for locating the cricothyroid membrane, particularly in patients with difficult anatomy. Finally, we provide an algorithm for using ultrasound to manage the crashing patient on mechanical ventilation. After reading this article, readers will have an enhanced understanding of the role of ultrasound in airway management.

气道管理是急诊和重症医学中的常见程序。预测和处理困难气道的传统技术都有很大的局限性。随着该领域的不断发展,床旁超声越来越多地被用于这一应用。超声波可用于预测困难气道的几种测量方法,包括皮肤到会厌的距离、舌骨距离和舌厚度。超声还可用于确认气管插管和评估气管插管深度。在定位环甲膜方面,超声比基于地标的方法更有优势,尤其是对于解剖结构复杂的患者。最后,我们还提供了一种使用超声管理机械通气患者的算法。阅读本文后,读者将对超声在气道管理中的作用有更深入的了解。
{"title":"Point-of-care ultrasound for airway management in the emergency and critical care setting.","authors":"Michael Gottlieb, James R O'Brien, Nicholas Ferrigno, Tina Sundaram","doi":"10.15441/ceem.23.094","DOIUrl":"10.15441/ceem.23.094","url":null,"abstract":"<p><p>Airway management is a common procedure within emergency and critical care medicine. Traditional techniques for predicting and managing a difficult airway each have important limitations. As the field has evolved, point-of-care ultrasound has been increasingly utilized for this application. Several measures can be used to sonographically predict a difficult airway, including skin to epiglottis, hyomental distance, and tongue thickness. Ultrasound can also be used to confirm endotracheal tube intubation and assess endotracheal tube depth. Ultrasound is superior to the landmark-based approach for locating the cricothyroid membrane, particularly in patients with difficult anatomy. Finally, we provide an algorithm for using ultrasound to manage the crashing patient on mechanical ventilation. After reading this article, readers will have an enhanced understanding of the role of ultrasound in airway management.</p>","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"22-32"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009714/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10123569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and demonstration of the protective efficacy of a convertible respiratory barrier enclosure: a simulation study. 一种可转换呼吸屏障罩的开发和防护效果的论证:模拟研究。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2023-11-29 DOI: 10.15441/ceem.23.067
Min Ho Park, Ki Sub Sung, Ji Hoon Kim, Jinwoo Myung, Ju Young Hong

Objective: The efficacy of previously developed respiratory barrier enclosures to limit healthcare workers' exposure to aerosols from COVID-19 patients remains unclear; in addition, the design of these devices is unsuitable for transportation or other emergency procedures. Therefore, we developed a novel negative pressure respiratory isolator to improve protection from patient-generated aerosols and evaluated its protective effect in conversion to systemic isolator.

Methods: This in vitro study simulated droplets by nebulizing 1% glycerol + 99% ethanol solution. We performed cardiopulmonary resuscitation (CPR) and converted a respiratory barrier enclosure into a systemic isolator with a respiratory barrier as well as a respiratory barrier with negative pressure generator (NPG), which were compared with control and room air. During the procedure, particles were counted for 30 seconds and the count was repeated 10 times.

Results: During CPR, the total number of particles in the respiratory barrier with NPG (280,529; interquartile range [IQR], 205,263-359,195; P=0.970) was similar to that in the control (308,789; IQR, 175,056-473,276). Using NPG with a respiratory barrier reduced the number of particles to 27,524 (IQR, 26,703- 28,905; P=0.001). Particle number during conversion of the respiratory barrier into a systemic isolator was also lower than in the control (25,845; IQR, 19,391- 29,772; P=0.001).

Conclusion: The novel isolator was converted to a systemic isolator without air leakage. The aerosol-blocking effect of the isolator was quantified using a particle counter during CPR. Further studies comparing the barrier effect of isolators within various pressure differentials are warranted.

目的:目前尚不清楚先前开发的呼吸屏障对限制医护人员接触COVID-19患者气溶胶的效果;此外,这些装置的设计不适合运输或其他紧急程序。因此,我们开发了一种新型负压呼吸隔离器,以提高对患者产生的气溶胶的保护,并评估了其转化为全身隔离器的保护效果。方法:采用1%甘油+ 99%乙醇溶液雾化的方法进行体外模拟液滴实验。我们进行了心肺复苏(CPR),并将呼吸屏障围栏转换为带呼吸屏障的系统隔离器和带负压发生器的呼吸屏障(NPG),并与对照组和室内空气进行了比较。在此过程中,粒子计数30秒,计数重复10次。结果:心肺复苏术时,呼吸屏障内NPG颗粒总数(280,529;四分位间距[IQR], 205,263-359,195;P=0.9702)与对照组(308,789;差,175056 - 473276)。使用带有呼吸屏障的NPG可将颗粒数减少到27,524 (IQR, 26,703-28,905;P = 0.0014)。在将呼吸屏障转化为系统隔离器的过程中,颗粒数也低于对照组(25,845;差,19391 - 29772;P = 0.0014)。结论:将新型隔离器改造为无漏气的系统隔离器。在CPR过程中使用粒子计数器定量隔离器的气溶胶阻断效应。进一步的研究比较不同压差下隔离器的屏障效应是必要的。
{"title":"Development and demonstration of the protective efficacy of a convertible respiratory barrier enclosure: a simulation study.","authors":"Min Ho Park, Ki Sub Sung, Ji Hoon Kim, Jinwoo Myung, Ju Young Hong","doi":"10.15441/ceem.23.067","DOIUrl":"10.15441/ceem.23.067","url":null,"abstract":"<p><strong>Objective: </strong>The efficacy of previously developed respiratory barrier enclosures to limit healthcare workers' exposure to aerosols from COVID-19 patients remains unclear; in addition, the design of these devices is unsuitable for transportation or other emergency procedures. Therefore, we developed a novel negative pressure respiratory isolator to improve protection from patient-generated aerosols and evaluated its protective effect in conversion to systemic isolator.</p><p><strong>Methods: </strong>This in vitro study simulated droplets by nebulizing 1% glycerol + 99% ethanol solution. We performed cardiopulmonary resuscitation (CPR) and converted a respiratory barrier enclosure into a systemic isolator with a respiratory barrier as well as a respiratory barrier with negative pressure generator (NPG), which were compared with control and room air. During the procedure, particles were counted for 30 seconds and the count was repeated 10 times.</p><p><strong>Results: </strong>During CPR, the total number of particles in the respiratory barrier with NPG (280,529; interquartile range [IQR], 205,263-359,195; P=0.970) was similar to that in the control (308,789; IQR, 175,056-473,276). Using NPG with a respiratory barrier reduced the number of particles to 27,524 (IQR, 26,703- 28,905; P=0.001). Particle number during conversion of the respiratory barrier into a systemic isolator was also lower than in the control (25,845; IQR, 19,391- 29,772; P=0.001).</p><p><strong>Conclusion: </strong>The novel isolator was converted to a systemic isolator without air leakage. The aerosol-blocking effect of the isolator was quantified using a particle counter during CPR. Further studies comparing the barrier effect of isolators within various pressure differentials are warranted.</p>","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"59-67"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138451006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introduction and application of a metaverse platform used in Chosun University Hospital Metaverse. 基于 ZEP 的虚拟医院元数据平台(朝鲜大学医院元数据平台)的介绍和应用。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2024-01-11 DOI: 10.15441/ceem.23.086
Mi Ra Kim, Hee Jeong Noh, Ji Yun Choi, Kyung Jong Kim, Yoseup Kim
{"title":"Introduction and application of a metaverse platform used in Chosun University Hospital Metaverse.","authors":"Mi Ra Kim, Hee Jeong Noh, Ji Yun Choi, Kyung Jong Kim, Yoseup Kim","doi":"10.15441/ceem.23.086","DOIUrl":"10.15441/ceem.23.086","url":null,"abstract":"","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"106-114"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009712/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139416541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of clinical study designs. 临床研究设计概述。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2023-06-02 DOI: 10.15441/ceem.23.036
Seonwoo Kim

The goal of a clinical study is to determine the factors associated with a disease and to assess the efficacy and safety of an investigational drug, procedure, or device. Since clinical study designs vary due to unique requirements of individual studies, the aims of this report are to educate researchers on the different types of studies and to assist researchers in choosing the optimal study type to fulfill their individual requirements. Clinical studies are classified into the two main types, observational studies and clinical trials, depending on the presence or absence of an intervention. Observational studies include case-control studies, cohort studies, and cross-sectional studies. Case-control and cohort studies may be prospective or retrospective, and case-control studies may be nested or not. Clinical trials may be pragmatic and may be controlled or noncontrolled; randomized or nonrandomized; open label or blinded; and parallel, crossover, or factorial. These observational and clinical trial designs are reviewed. Each type of clinical study has advantages and disadvantages. Therefore, researchers must consider these in choosing the design best suited for achieving their study objectives.

临床研究的目的是确定与疾病相关的因素,并评估研究药物、程序或设备的有效性和安全性。由于临床研究设计因各项研究的独特要求而各不相同,本报告旨在向研究人员介绍不同类型的研究,并帮助研究人员选择最佳的研究类型,以满足他们的个性化要求。临床研究根据有无干预措施可分为观察研究和临床试验两大类。观察性研究包括病例对照研究、队列研究和横断面研究。病例对照研究和队列研究可以是前瞻性的,也可以是回顾性的;病例对照研究可以是嵌套的,也可以是不嵌套的。临床试验可能是务实的,可能是对照或非对照;随机或非随机;开放标签或盲法;平行、交叉或因子。本文对这些观察性和临床试验设计进行了综述。每种类型的临床研究都各有利弊。因此,研究人员在选择最适合实现其研究目标的设计时必须考虑这些因素。
{"title":"Overview of clinical study designs.","authors":"Seonwoo Kim","doi":"10.15441/ceem.23.036","DOIUrl":"10.15441/ceem.23.036","url":null,"abstract":"<p><p>The goal of a clinical study is to determine the factors associated with a disease and to assess the efficacy and safety of an investigational drug, procedure, or device. Since clinical study designs vary due to unique requirements of individual studies, the aims of this report are to educate researchers on the different types of studies and to assist researchers in choosing the optimal study type to fulfill their individual requirements. Clinical studies are classified into the two main types, observational studies and clinical trials, depending on the presence or absence of an intervention. Observational studies include case-control studies, cohort studies, and cross-sectional studies. Case-control and cohort studies may be prospective or retrospective, and case-control studies may be nested or not. Clinical trials may be pragmatic and may be controlled or noncontrolled; randomized or nonrandomized; open label or blinded; and parallel, crossover, or factorial. These observational and clinical trial designs are reviewed. Each type of clinical study has advantages and disadvantages. Therefore, researchers must consider these in choosing the design best suited for achieving their study objectives.</p>","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"33-42"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9583149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tranexamic acid for angiotensin-converting enzyme inhibitor-induced angioedema. 氨甲环酸治疗血管紧张素转换酶抑制剂诱发的血管性水肿。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2023-08-01 DOI: 10.15441/ceem.23.051
Gaurav Nitin Pathak, Thu Minh Truong, Abhishek Chakraborty, Babar Rao, Catherine Monteleone

Approximately 0.7% of patients taking angiotensin-converting enzyme inhibitors (ACEIs) develop ACEI-induced angioedema (ACEI-IA). With no approved treatments for ACEI-IA, the risk of complications is concerning. Tranexamic acid (TXA) has the potential to prevent intubations and resolve ACEI-IA by inhibiting the downstream production of bradykinin. In this review, we aim to evaluate the safety and efficacy of TXA use in ACEI-IA. We queried the PubMed database for studies involving TXA for ACEI-IA from January 2003 to January 2023. Seven studies met the study inclusion criteria. Our results demonstrate that TXA may improve angioedema symptoms and prevent intubation. In addition, its availability, low cost, and safety profile support its use for improving the symptoms and complications of ACEI-IA in an emergency setting.

在服用血管紧张素转换酶抑制剂(ACEI)的患者中,约有 0.7% 会出现 ACEI 引起的血管性水肿(ACEI-IA)。由于目前还没有获准治疗 ACEI-IA 的药物,并发症的风险令人担忧。氨甲环酸(TXA)可抑制缓激肽的下游生成,从而预防插管并缓解 ACEI-IA。在这篇综述中,我们旨在评估在 ACEI-IA 中使用氨甲环酸的安全性和有效性。我们在 PubMed 数据库中查询了 2003 年 1 月至 2023 年 1 月期间涉及 TXA 用于 ACEI-IA 的研究。有七项研究符合研究纳入标准。我们的研究结果表明,TXA 可以改善血管性水肿症状并防止插管。此外,TXA 的可用性、低成本和安全性也支持在急诊环境中用于改善 ACEI-IA 的症状和并发症。
{"title":"Tranexamic acid for angiotensin-converting enzyme inhibitor-induced angioedema.","authors":"Gaurav Nitin Pathak, Thu Minh Truong, Abhishek Chakraborty, Babar Rao, Catherine Monteleone","doi":"10.15441/ceem.23.051","DOIUrl":"10.15441/ceem.23.051","url":null,"abstract":"<p><p>Approximately 0.7% of patients taking angiotensin-converting enzyme inhibitors (ACEIs) develop ACEI-induced angioedema (ACEI-IA). With no approved treatments for ACEI-IA, the risk of complications is concerning. Tranexamic acid (TXA) has the potential to prevent intubations and resolve ACEI-IA by inhibiting the downstream production of bradykinin. In this review, we aim to evaluate the safety and efficacy of TXA use in ACEI-IA. We queried the PubMed database for studies involving TXA for ACEI-IA from January 2003 to January 2023. Seven studies met the study inclusion criteria. Our results demonstrate that TXA may improve angioedema symptoms and prevent intubation. In addition, its availability, low cost, and safety profile support its use for improving the symptoms and complications of ACEI-IA in an emergency setting.</p>","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"94-99"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9908322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unraveling the link between severe bradycardia and paraquat poisoning. 解开严重心动过缓与百草枯中毒之间的联系。
IF 1.9 Q2 Nursing Pub Date : 2024-03-01 Epub Date: 2024-01-11 DOI: 10.15441/ceem.23.068
Anitha Ramkumar, Tatavarti Murthy, Rajkumar Elanjeran, Y Vishnu Chaitanya, Kari Harika, Sasikumar Mahalingam, Gunaseelan Rajendiran
{"title":"Unraveling the link between severe bradycardia and paraquat poisoning.","authors":"Anitha Ramkumar, Tatavarti Murthy, Rajkumar Elanjeran, Y Vishnu Chaitanya, Kari Harika, Sasikumar Mahalingam, Gunaseelan Rajendiran","doi":"10.15441/ceem.23.068","DOIUrl":"10.15441/ceem.23.068","url":null,"abstract":"","PeriodicalId":10325,"journal":{"name":"Clinical and Experimental Emergency Medicine","volume":" ","pages":"117-119"},"PeriodicalIF":1.9,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009708/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139416545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical and Experimental Emergency Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1